Jim Meyers is a Senior Advisor to and core member of the Health Care practice at Boston Consulting Group. He joined the firm in January 2019, bringing 32 years of pharmaceutical experience.

Before coming to BCG, Jim most recently served as EVP and CCO at Gilead Sciences, where he oversaw and led the launch of 24 products, including 11 brands with peak annual revenue over $1 billion, and the two most successful launches in pharmaceutical history as measured by first year revenue. Jim has a deep understanding of the intersection of public policy, pricing, and access, and the current drug pricing debate in Washington DC.